The University of Chicago Header Logo

Peter Riedell

Concepts (130)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
11
2022
126
2.940
Why?
Hematopoietic Stem Cell Transplantation
11
2023
843
2.430
Why?
Immunotherapy, Adoptive
9
2022
145
2.330
Why?
Lymphoma, Mantle-Cell
2
2021
32
1.710
Why?
Lymphoma, B-Cell
5
2022
101
1.390
Why?
Antigens, CD19
7
2022
36
1.280
Why?
Transplantation, Autologous
6
2021
321
1.140
Why?
Lymphoma, Non-Hodgkin
2
2021
254
0.860
Why?
Proto-Oncogene Proteins c-myc
2
2018
109
0.830
Why?
Jehovah's Witnesses
1
2021
18
0.830
Why?
Blood Component Removal
1
2020
27
0.820
Why?
Proto-Oncogene Proteins c-bcl-2
2
2018
177
0.810
Why?
Transplantation Conditioning
3
2021
371
0.770
Why?
Lymphoma
2
2018
258
0.730
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2023
2346
0.590
Why?
Antibodies, Monoclonal, Murine-Derived
3
2016
77
0.590
Why?
Biological Products
3
2022
133
0.580
Why?
Receptors, Antigen, T-Cell
4
2022
373
0.580
Why?
Lymphoma, Follicular
3
2022
68
0.570
Why?
Graft vs Host Disease
3
2023
351
0.530
Why?
Hepatitis B virus
1
2014
38
0.520
Why?
Hepatitis B
1
2014
70
0.500
Why?
B-Lymphocytes
1
2017
723
0.470
Why?
Gene Expression Profiling
1
2017
1328
0.440
Why?
Humans
32
2023
80897
0.410
Why?
Neoplasm Recurrence, Local
6
2023
1219
0.310
Why?
Sarcopenia
2
2016
12
0.300
Why?
T-Lymphocytes
4
2021
1190
0.300
Why?
Retrospective Studies
5
2022
7560
0.300
Why?
Aged
12
2022
17475
0.270
Why?
Cell- and Tissue-Based Therapy
2
2021
44
0.260
Why?
Antineoplastic Agents
2
2015
2274
0.250
Why?
Veterans
4
2016
59
0.240
Why?
Rituximab
4
2016
103
0.230
Why?
Middle Aged
11
2022
23961
0.220
Why?
Hodgkin Disease
1
2023
172
0.220
Why?
Geriatric Assessment
2
2020
159
0.220
Why?
Thrombocytopenia
1
2022
171
0.210
Why?
5-Methylcytosine
1
2022
101
0.210
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2022
131
0.210
Why?
Prognosis
2
2018
3544
0.200
Why?
Cladribine
1
2019
35
0.190
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2020
39
0.190
Why?
Survival Analysis
2
2021
1512
0.190
Why?
Hematologic Neoplasms
1
2023
313
0.180
Why?
Antineoplastic Agents, Immunological
1
2021
181
0.180
Why?
Adult
7
2022
24636
0.180
Why?
Interdisciplinary Communication
1
2019
124
0.180
Why?
United States
6
2022
6169
0.180
Why?
Patient Selection
2
2019
661
0.180
Why?
Male
12
2022
39412
0.170
Why?
Disease Management
1
2019
317
0.160
Why?
Preoperative Care
1
2019
382
0.160
Why?
Patient Care Team
1
2019
268
0.160
Why?
Central Nervous System Neoplasms
1
2018
78
0.160
Why?
Multiple Myeloma
1
2020
296
0.160
Why?
Translocation, Genetic
1
2017
261
0.160
Why?
Cyclophosphamide
4
2021
288
0.150
Why?
Obesity, Abdominal
1
2016
7
0.150
Why?
Female
11
2022
42456
0.150
Why?
Body Composition
1
2016
63
0.150
Why?
Up-Regulation
1
2018
692
0.140
Why?
Maximum Tolerated Dose
1
2016
267
0.140
Why?
Stem Cell Transplantation
3
2021
176
0.140
Why?
Anthracyclines
1
2015
34
0.140
Why?
Pneumonia, Viral
1
2020
302
0.130
Why?
Doxorubicin
4
2016
280
0.130
Why?
Coronavirus Infections
1
2020
286
0.130
Why?
Survivors
1
2016
209
0.130
Why?
Febrile Neutropenia
1
2014
14
0.130
Why?
Pandemics
1
2020
628
0.130
Why?
Venous Thromboembolism
1
2016
121
0.130
Why?
Leukemia, Myeloid, Acute
1
2019
696
0.130
Why?
Transplantation, Homologous
3
2020
978
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2018
1163
0.120
Why?
Clinical Trials as Topic
1
2018
1142
0.120
Why?
Time Factors
1
2021
5094
0.110
Why?
Vincristine
3
2016
107
0.110
Why?
Prednisone
3
2016
252
0.100
Why?
Body Mass Index
1
2014
743
0.100
Why?
Antiviral Agents
1
2014
488
0.100
Why?
Recurrence
2
2023
1118
0.090
Why?
Adolescent
1
2021
8669
0.090
Why?
Pilot Projects
2
2021
795
0.090
Why?
Antibodies, Monoclonal
1
2014
1363
0.080
Why?
Prospective Studies
3
2023
3926
0.080
Why?
Aged, 80 and over
3
2021
6214
0.060
Why?
Melphalan
1
2023
95
0.060
Why?
Thiotepa
1
2021
32
0.050
Why?
Histiocytes
1
2021
22
0.050
Why?
B7-H1 Antigen
1
2023
223
0.050
Why?
Incidence
2
2016
1540
0.050
Why?
Treatment Outcome
3
2019
7492
0.050
Why?
Central Nervous System
1
2021
144
0.050
Why?
Health Planning Guidelines
1
2019
24
0.050
Why?
Chimerism
1
2020
36
0.050
Why?
Filgrastim
1
2019
56
0.050
Why?
Communicable Disease Control
1
2020
48
0.050
Why?
Hydrazines
1
2019
29
0.050
Why?
Health Care Rationing
1
2020
77
0.050
Why?
Health Plan Implementation
1
2019
55
0.050
Why?
Standard of Care
1
2019
86
0.050
Why?
Triazoles
1
2019
96
0.050
Why?
Cytarabine
1
2019
211
0.050
Why?
Drug Resistance, Neoplasm
1
2021
561
0.040
Why?
Epigenesis, Genetic
1
2022
437
0.040
Why?
Remission Induction
1
2019
705
0.040
Why?
Palliative Care
1
2019
234
0.040
Why?
Clinical Decision-Making
1
2019
243
0.040
Why?
Tissue Donors
1
2020
419
0.040
Why?
Steroids
1
2018
165
0.040
Why?
Abdominal Fat
1
2016
13
0.040
Why?
Subcutaneous Fat
1
2016
16
0.040
Why?
Neutropenia
1
2016
211
0.040
Why?
Cohort Studies
1
2021
2583
0.030
Why?
Antibiotics, Antineoplastic
1
2015
108
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2020
901
0.030
Why?
Proportional Hazards Models
1
2016
824
0.030
Why?
Muscle, Skeletal
1
2016
426
0.030
Why?
Longitudinal Studies
1
2016
948
0.030
Why?
Mice, Inbred C57BL
1
2019
3052
0.030
Why?
Practice Guidelines as Topic
1
2020
1013
0.030
Why?
Animals
2
2023
25628
0.030
Why?
Hospitalization
1
2016
768
0.030
Why?
Mutation
1
2022
3792
0.030
Why?
Mice
1
2023
10809
0.020
Why?
Young Adult
1
2019
5725
0.020
Why?
Tomography, X-Ray Computed
1
2016
2440
0.020
Why?
Magnetic Resonance Imaging
1
2018
3114
0.020
Why?
Risk Factors
1
2016
5137
0.020
Why?
Riedell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_